These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16454736)

  • 1. Antibody-like peptides as a novel purification tool for drugs design.
    Tozzi C; Giraudi G
    Curr Pharm Des; 2006; 12(2):191-203. PubMed ID: 16454736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity chromatography techniques based on the immobilisation of peptides exhibiting specific binding activity.
    Tozzi C; Anfossi L; Giraudi G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Nov; 797(1-2):289-304. PubMed ID: 14630156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative Affinity Ligands for Immunoglobulins.
    Kruljec N; Bratkovič T
    Bioconjug Chem; 2017 Aug; 28(8):2009-2030. PubMed ID: 28696676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptides and pseudopeptide ligands: a powerful toolbox for the affinity purification of current and next-generation biotherapeutics.
    Chu W; Prodromou R; Day KN; Schneible JD; Bacon KB; Bowen JD; Kilgore RE; Catella CM; Moore BD; Mabe MD; Alashoor K; Xu Y; Xiao Y; Menegatti S
    J Chromatogr A; 2021 Jan; 1635():461632. PubMed ID: 33333349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review on biomimetic affinity chromatography with short peptide ligands and its application to protein purification.
    Fang YM; Lin DQ; Yao SJ
    J Chromatogr A; 2018 Oct; 1571():1-15. PubMed ID: 30097342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide Affinity Chromatography Applied to Therapeutic Antibodies Purification.
    Barredo-Vacchelli GR; Giudicessi SL; Martínez-Ceron MC; Cascone O; Camperi SA
    Int J Pept Res Ther; 2021; 27(4):2905-2921. PubMed ID: 34690622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrices and Affinity Ligands for Antibody Purification and Corresponding Applications in Radiotherapy.
    Xue A; Fan S
    Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity chromatography matures as bioinformatic and combinatorial tools develop.
    Clonis YD
    J Chromatogr A; 2006 Jan; 1101(1-2):1-24. PubMed ID: 16242704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and refinement of peptide mimetic ligands for paratope-specific purification of monoclonal antibodies.
    Murray A; Smith RG; Brady K; Williams S; Badley RA; Price MR
    Anal Biochem; 2001 Sep; 296(1):9-17. PubMed ID: 11520027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Past, Present, and Future of Affinity-based Cell Separation Technologies.
    Bacon K; Lavoie A; Rao BM; Daniele M; Menegatti S
    Acta Biomater; 2020 Aug; 112():29-51. PubMed ID: 32442784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel ligands for the affinity-chromatographic purification of antibodies.
    Fassina G; Ruvo M; Palombo G; Verdoliva A; Marino M
    J Biochem Biophys Methods; 2001 Oct; 49(1-3):481-90. PubMed ID: 11694296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary peptides as antibody mimetics for protein purification and assay.
    Fassina G
    Immunomethods; 1994 Oct; 5(2):121-9. PubMed ID: 7874436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity chromatography: A versatile technique for antibody purification.
    Arora S; Saxena V; Ayyar BV
    Methods; 2017 Mar; 116():84-94. PubMed ID: 28012937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downstream Processing of Therapeutic Peptides by Means of Preparative Liquid Chromatography.
    De Luca C; Lievore G; Bozza D; Buratti A; Cavazzini A; Ricci A; Macis M; Cabri W; Felletti S; Catani M
    Molecules; 2021 Aug; 26(15):. PubMed ID: 34361839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A solid-phase combinatorial approach for indoloquinolizidine-peptides with high affinity at D(1) and D(2) dopamine receptors.
    Molero A; Vendrell M; Bonaventura J; Zachmann J; López L; Pardo L; Lluis C; Cortés A; Albericio F; Casadó V; Royo M
    Eur J Med Chem; 2015 Jun; 97():173-80. PubMed ID: 25969169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity-based methodologies and ligands for antibody purification: advances and perspectives.
    Roque AC; Silva CS; Taipa MA
    J Chromatogr A; 2007 Aug; 1160(1-2):44-55. PubMed ID: 17618635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies and genetically engineered related molecules: production and purification.
    Roque AC; Lowe CR; Taipa MA
    Biotechnol Prog; 2004; 20(3):639-54. PubMed ID: 15176864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic peptide ligand with high binding capacity for affinity purification of immunoglobulin G.
    Kang HJ; Choe W; Min JK; Lee YM; Kim BM; Chung SJ
    J Chromatogr A; 2016 Sep; 1466():105-12. PubMed ID: 27608618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity purification of IgG monoclonal antibodies using the D-PAM synthetic ligand: chromatographic comparison with protein A and thermodynamic investigation of the D-PAM/IgG interaction.
    D'Agostino B; Bellofiore P; De Martino T; Punzo C; Rivieccio V; Verdoliva A
    J Immunol Methods; 2008 Apr; 333(1-2):126-38. PubMed ID: 18313690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleic acid aptamers as high affinity ligands in biotechnology and biosensorics.
    Šmuc T; Ahn IY; Ulrich H
    J Pharm Biomed Anal; 2013; 81-82():210-7. PubMed ID: 23666257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.